Legal Representation
Attorney
Melissa W. Woo-Allen
USPTO Deadlines
Application History
15 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Mar 9, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Mar 9, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
Aug 6, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Jun 11, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jun 11, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
May 22, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
May 6, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
Apr 22, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Apr 19, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Apr 19, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Apr 19, 2019 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Apr 19, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Apr 19, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Mar 1, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Feb 11, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of glaucoma and hypertension
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the word "ROCKLATAN" in lower case block letters with "ROCK" in a darker shade than "LATAN" with the words "NETARSUDIL/LATANOPROST OPHTHALMIC SOLUTION" in parentheses followed by "0.02%/0.005%" beneath the word "ROCKLATAN".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"(NETARSUDIL/LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005%"